Upcoming Webinar

Accelerating Rare Disease Drug Development with Wearable Digital Health Technologies

Date Icon

Wednesday, April 26, 2023  |  11 AM ET


More than 90% of rare diseases do not have any treatment, representing a substantial unmet need for patients. The development of new therapies is especially challenging given the poor understanding of rare diseases in general and the lack of established endpoints for clinical trials.

Sensor-based digital health technologies (DHTs), such as low-burden wearable devices, offer new opportunities to advance rare disease research by providing patient-centric, objective measures on how patients function in the real world.

During this 60-minute webinar, experts from ActiGraph, Bellerophon Therapeutics,  IQVIA, and Stanford University will discuss these challenges and opportunities, including a case study on how digital measures of physical activity are being used as a primary endpoint in a pivotal trial, enabling the reduction of the sample size by a factor of two.

Learning Objectives

  • Identify unmet needs and challenges of developing treatment for rare disease
  • Discover opportunities for wearable and sensor-based DHTs
  • Hear a case study about how Bellerophon Therapeutics is using digital measures of physical activity as a primary endpoint in a pivotal trial


Christine Guo, PhD

Christine Guo, PhD

Chief Scientific Officer
Sylvain Zorman, PhD

Sylvain Zorman, PhD

Director of Digital Health Science


Peter Fernandes

Peter Fernandes

Chief Executive Officer

Bellerophon Therapeutics

Salma Ajraoui, PhD

Salma Ajraoui, PhD

Digital Practice Lead, Patient Centered Solutions


Tina Duong

Tina Duong, PT PhD

Director of Clinical Outcomes Research and Development

Stanford University Neuromuscular Division

Register for the Webinar